Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Becker, S. Chohan (2008)
We can make gout management more successful nowCurrent Opinion in Rheumatology, 20
J. Ly, P. Gow, N. Dalbeth (2007)
Colchicine prescribing and safety monitoring in patients with gout.The New Zealand medical journal, 120 1265
K. Hoskison, R. Wortmann (2007)
Management of Gout in Older AdultsDrugs & Aging, 24
A. Tausche, T. Jansen, H. Schröder, S. Bornstein, M. Aringer, U. Müller-Ladner (2009)
Gout--current diagnosis and treatment.Deutsches Arzteblatt international, 106 34-35
D. Winnard, T. Kake, P. Gow, C. Barratt-Boyes, V. Harris, Devi-ann Hall, H. Mason, T. Merriman, N. Dalbeth (2008)
Debunking the myths to provide 21st Century management of gout.The New Zealand medical journal, 121 1274
C. Sarawate, P. Patel, Wenya Yang, K. Brewer, A. Bakst (2006)
Serum Urate Levels and Gout Flares: Analysis From Managed Care DataJCR: Journal of Clinical Rheumatology, 12
Choi (2010)
Genetics of gout.Curr Opin Rheumatol, 22
P. Thiele, Schröder He (1982)
[Epidemiology of hyperuricemia and gout].Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 37 13
L. Harrold, S. Andrade, B. Briesacher, M. Raebel, H. Fouayzi, R. Yood, I. Ockene (2009)
Adherence with urate-lowering therapies for the treatment of goutArthritis Research & Therapy, 11
L. Harrold, S. Andrade, B. Briesacher, M. Raebel, H. Fouayzi, R. Yood, I. Ockene (2010)
The dynamics of chronic gout treatment: medication gaps and return to therapy.The American journal of medicine, 123 1
Dalbeth (2007)
Treatment of gouthit the target.Best Pract J, 8
(2004)
An update on gout. An overview of current research and practice in rheumatic disease
E. Roddy, Weiya Zhang, M. Doherty (2007)
The changing epidemiology of goutNature Clinical Practice Rheumatology, 3
G. Nuki (2006)
Events provoking acute gouty arthritisMedicine, 10
(2008)
Out With Gout: How to Live a Healthy Life With Gout
Richette (2010)
Gout.Lancet, 375
Hyon Choi (2010)
A prescription for lifestyle change in patients with hyperuricemia and goutCurrent Opinion in Rheumatology, 22
(2006)
Medicine (Baltimore)
F. Stevenson, K. Cox, N. Britten, Y. Dundar (2004)
A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordanceHealth Expectations, 7
P. Riches (2012)
Chapter 7 – Genetics of Gout
(2012)
Gout and its managementVthe devil is in the detail
C. Agudelo, C. Wise (1989)
Gout and hyperuricemiaCurrent Opinion in Rheumatology, 3
M. Doherty (2009)
New insights into the epidemiology of gout.Rheumatology, 48 Suppl 2
P. Klemp, S. Stansfield, Benjamin Castle, M. Robertson (1997)
Gout is on the increase in New ZealandAnnals of the Rheumatic Diseases, 56
Luk (2005)
Epidemiology of hyperuricemia and gout.Am J Manag Care, 11
Jade Hollis-Moffatt, Xin Xu, N. Dalbeth, M. Merriman, R. Topless, C. Waddell, P. Gow, A. Harrison, J. Highton, Peter Jones, L. Stamp, T. Merriman (2009)
Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets.Arthritis and rheumatism, 60 11
H. Puspitasari, P. Aslani, I. Krass (2009)
A review of counseling practices on prescription medicines in community pharmacies.Research in social & administrative pharmacy : RSAP, 5 3
Li Zhang, H. Schumacher, H. Su, D. Lie, Janet Dinnella, J. Baker, J. Feldt (2011)
Development and Evaluation of a Survey of Gout Patients Concerning Their Knowledge About GoutJournal of Clinical Rheumatology, 17
J. Sundy (2010)
Progress in the pharmacotherapy of goutCurrent Opinion in Rheumatology, 22
Wortmann (2002)
Gout and hyperuricemia.Curr Opin Rheumatol, 14
ORIGINAL ARTICLE Living With Gout in New Zealand An Exploratory Study Into People’s Knowledge About the Disease and Its Treatment Nataly Martini, PhD,* Linda Bryant, PhD,* Leanne Te Karu, PGDipClinPharm,Þ Lenati Aho, BPharm,* Richard Chan, BPharm,* Jing Miao, BPharm,* Caylee Naidoo, BPharm,* Harjinder Singh, BPharm,* and Amanda Tieu, BPharm* of those of European descent. Other possible risk factors for Background: In New Zealand, gout disproportionately affects Ma¯ori developing gout such as central obesity, hyperglycemia, hyper- and Pacific people who also experience symptoms at an earlier age. Gout 4,8,10,11 triglyceridemia, and hypertension are particularly con- occurs predominantly in men and is associated with cardiovascular dis- cerning in Counties Manukau, where 59% of people with gout ease, diabetes, and renal disease. The impact on daily social activities, are classified as high risk for having a cardiovascular event family, and work is enormous, and many people remain inadequately within the next 5 years. treated. Symptoms are usually experienced by middle-aged men, Objectives: The objectives of this study were to explore the knowledge with a peak incidence at 40 to 50 years, although in Counties and perceptions of people with gout toward the disease and to determine Manukau, Ma¯ori and Pacific men have
JCR: Journal of Clinical Rheumatology – Wolters Kluwer Health
Published: Apr 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.